EE336 Budget Impact Analysis of Nefecon for the Treatment of Primary IgA Nephropathy in the United States

Abstract

Authors

S Hwang L Ramjee M Patel C Ngai G Tremblay

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×